Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Dosimetric considerations relative to radionuclides for thyroid diagnosis and therapy. [/sup 125/I, /sup 123/I and /sup 99m/Tc compared with /sup 131/I]

Conference ·
OSTI ID:7193111
Recent changes have occurred in the radionuclidic approach to the diagnosis and therapy of thyroid diseases. These changes have been directed toward reduction of radiation dose by the use of short-lived radionuclides for imaging and toward better control of late effects of therapy by substituting iodine-125 for iodine-131. Imaging of the thyroid is now widely performed following the administration of technetium-99m or iodine-123. Some problems exist relative to the use of technetium-99m in that the distribution of radioactivity in the thyroid is not always identical to the distribution of radioiodine. Iodine-123 represents a substantial advance over iodine-131 despite contamination of the former with small amounts of other radioiodines. The high incidence of induced hypothyroidism following iodine-131 therapy of thyrotoxicosis has spurred interest in the use of iodine-125. The biological effectiveness of iodine-125 is believed to be greater because of the high abundance of Auger electrons and possibly because of chemical effects following molecular disruption. Clinical results to date are discussed. (auth)
Research Organization:
Brookhaven National Lab., Upton, N.Y. (USA)
OSTI ID:
7193111
Report Number(s):
BNL-21313; CONF-760444-8
Country of Publication:
United States
Language:
English

Similar Records

Radiobiological effects of /sup 131/I and /sup 125/I on the DNA of the rat thyroid
Journal Article · Mon Feb 28 23:00:00 EST 1983 · Radiat. Res.; (United States) · OSTI ID:5896217

Treatment of hyperthyroidism: use of 131I and 125I
Conference · Fri Dec 31 23:00:00 EST 1976 · OSTI ID:7103804

Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: Correlation with pathologic findings
Journal Article · Sat Mar 31 23:00:00 EST 1990 · Journal of Nuclear Medicine; (USA) · OSTI ID:6896236